Company Filing History:
5 out of 5 
3 out of 366 
1 out of 1 Years Active: 1997-2004
Title: Gregor Reid: Innovator in Microbial Therapy
Introduction
Gregor Reid is a prominent inventor based in London, Canada, known for his significant contributions to the field of microbial therapy. With a total of 9 patents, Reid has focused on developing innovative solutions for treating infections and enhancing health through probiotic therapies.
Latest Patents
Among his latest patents, Reid has developed a method for the treatment of microbial infections using bacterial proteins and peptides. This invention relates to protein and peptide chemistry, specifically the discovery and isolation of novel peptides derived from microorganism by-products, including biosurfactants. These peptides are utilized to inhibit infections caused by various pathogens. Another notable patent is centered on probiotic therapy for newborns. This invention involves probiotic microbes, such as Lactobacillus and Bifidobacteria species, and outlines methods for using these compositions to treat and prevent intestinal infections in newborn infants. The invention emphasizes the role of probiotic organisms in both viable and nonviable states in combating pathogenic infections.
Career Highlights
Throughout his career, Gregor Reid has worked with several notable companies, including Urex Biotech, Inc. and Research Corporation Technologies, Inc. His work has significantly impacted the field of microbiology and therapeutic interventions.
Collaborations
Reid has collaborated with esteemed colleagues, including Andrew W. Bruce and Henk J. Busscher, contributing to advancements in microbial research and therapy.
Conclusion
Gregor Reid's innovative work in microbial therapy and probiotic treatments showcases his dedication to improving health outcomes through scientific research. His patents reflect a commitment to addressing critical health challenges, particularly in vulnerable populations such as newborns.